Mission Statement, Vision, & Core Values (2026) of Bausch + Lomb Corporation.

Step into the legacy of Bausch + Lomb Corporation, where a founding year of 1853 anchors a global eye‑health mission-' help people see better to live better '-that now drives a portfolio of approximately 400 products across contact lenses, intraocular lenses, surgical devices and prescription medications; headquartered in Vaughan, Ontario and operating in over 100 countries with roughly 13,000 employees, BLCO marked a modern milestone when it began trading under the ticker BLCO in 2022 on the NYSE and TSX, while a forward‑looking vision to 'protect and enhance the gift of sight through every phase of life' and the FOCUS core values-Accountability, Agility, Results Orientation, Courage, Teamwork and Integrity-steer innovation, sustainability efforts and patient‑centered R&D that aim to translate nearly two centuries of expertise into measurable impact for millions worldwide.

Bausch + Lomb Corporation (BLCO) Intro

Bausch + Lomb Corporation (BLCO), founded in 1853, is a leading global eye health company dedicated to protecting and enhancing the gift of sight for millions worldwide. Headquartered in Vaughan, Ontario, BLCO develops, manufactures, and markets a comprehensive portfolio of products spanning contact lenses, intraocular lenses, surgical devices, and prescription eye medications.

• Portfolio size: approximately 400 products across retail, surgical, and pharmaceutical segments.
• Global footprint: operations in over 100 countries.
• Workforce: approximately 13,000 employees worldwide.
• Public listing: began trading under the ticker 'BLCO' on the New York Stock Exchange and Toronto Stock Exchange in 2022.

Mission

• To protect and enhance the gift of sight by delivering trusted, high-quality eye health products and innovations that improve patient outcomes and quality of life.
• To provide access to eye care solutions globally through clinical excellence, research-driven product development, and broad commercial reach.

Vision

• To be the global leader in eye health - advancing sight, creating value for patients and customers, and shaping the future of vision care.
• To build a sustainable enterprise that leverages nearly two centuries of innovation to address unmet needs in eye health worldwide.

Core Values

• Patient-centered care: prioritizing safety, efficacy, and accessibility of products.
• Innovation: investing in R&D to drive better clinical outcomes and next-generation technologies.
• Quality & integrity: maintaining rigorous manufacturing and regulatory standards.
• Collaboration: working with clinicians, payers, and partners to extend the impact of eye care solutions.
• Responsibility: committing to ethical governance, environmental stewardship, and community engagement.

Sustainability & Social Responsibility

• Programs to expand access to vision care in underserved regions through partnerships, donations, and outreach.
• Environmental initiatives focused on reducing manufacturing emissions, improving waste management, and responsible sourcing across the supply chain.
• Workplace policies aimed at employee safety, diversity, equity, and inclusion to support a global workforce of ~13,000.

For investors and stakeholders seeking deeper financial and investor-relations context, see Exploring Bausch + Lomb Corporation Investor Profile: Who's Buying and Why?

Bausch + Lomb Corporation (BLCO) - Overview

• Mission focus: improve vision and quality of life through innovative eye‑health solutions.
• Patient centricity: design and deliver products that prioritize patient outcomes and daily functioning.
• Enduring commitment: the mission has remained constant since 1853, providing continuity across decades of innovation.
• Global reach: delivering eye‑care products and services across more than 100 countries.

• R&D intensity to address evolving eye‑health needs (therapeutics, surgical, contact lenses, and vision care).
• Partnerships with clinicians, health systems, and patient groups to translate research into real-world outcomes.
• Product breadth aligned with life‑improvement - from daily disposable contact lenses to specialty surgical platforms.

• Vision: be the trusted partner in eye health - expanding access, improving outcomes, and innovating across prevention, correction, and treatment.
• Strategic focus areas: scale access to vision care globally, advance clinical evidence for new therapies and devices, and optimize product portfolios to meet diverse patient needs.

• Clinical pipeline advancement: sustained investment in clinical trials and regulatory submissions to bring new ophthalmic treatments to market.
• Access programs: distribution and affordability initiatives targeting underserved regions to increase reach and adherence.
• Quality & safety: manufacturing and post‑market surveillance aligned with global regulatory standards to protect patients.

Bausch + Lomb Corporation (BLCO) - Mission Statement

• Commit to evidence‑based innovation in contact lenses, lens care, ophthalmic pharmaceuticals, and surgical devices.
• Ensure broad access to affordable eye care and vision‑preserving therapies globally.
• Partner with clinicians and researchers to translate clinical science into better patient outcomes.
• Maintain rigorous quality and regulatory standards across all markets.

• Holistic eye‑care: preventive products (vision screening, lens care), corrective solutions (daily, monthly, specialty contact lenses), and therapeutic offerings (ophthalmic drugs, surgical devices).
• Lifecycle focus: pediatric myopia management through adult refractive correction to age‑related ocular disease treatment.
• Integration with clinical care: clinical trials, real‑world evidence, and clinician training to elevate standards of care.

• Pipeline emphasis on therapeutic ophthalmic agents and myopia‑management solutions for children.
• Continuous improvement of daily and specialty contact lens platforms to address diverse refractive needs.
• Investment in clinician education and point‑of‑care diagnostics to strengthen preventive care pathways.

Bausch + Lomb Corporation (BLCO) - Vision Statement

• Accountability - taking ownership of outcomes across R&D, manufacturing, regulatory compliance, and commercial operations to ensure patient safety and product reliability.
• Agility - responding quickly to market shifts, supply-chain challenges, and clinical evidence to maintain continuity of care and competitive advantage.
• Results Orientation - prioritizing measurable clinical and commercial results to drive growth, adoption, and shareholder value.
• Courage - making bold decisions in innovation, portfolio reshaping, and market expansion to address unmet needs in ophthalmology.
• Teamwork - leveraging cross-functional collaboration across scientists, clinicians, manufacturing, and global commercial teams to execute strategy.
• Integrity - upholding ethical conduct, regulatory compliance, and transparent communication with patients, providers, partners, and investors.

• Product development: rapid iteration on formulations and surgical technologies guided by clinical evidence and regulatory rigor.
• Commercial execution: coordinated global launches and market access initiatives that balance speed with compliance.
• Operational resilience: combining accountability and agility to reduce downtime, manage inventory, and secure supply chains.
• Culture & people: fostering teamwork and integrity through training, performance metrics, and clear governance frameworks.

• Advance pipeline in ophthalmic pharmaceuticals, specialty contact lenses, and surgical technologies through prioritized R&D spend and strategic partnerships.
• Drive margin expansion and operational efficiency by embedding accountability and results orientation in manufacturing and supply-chain programs.
• Expand access in emerging markets by deploying agile commercial models and local partnerships to improve affordability and reach.
• Preserve trust and compliance through robust governance, ethical sourcing, and transparent safety reporting aligned with integrity.